BATCH TESTING & BATCH RELEASE

BATCH TESTING & BATCH RELEASE

Kymos offers GMP-certified importation, batch testing and batch release services. We have several QPs and are certified importers and manufacturers (MIA holders) for quality control and batch certification of human, veterinary and investigational medicinal products (IMPs). Kymos has the capabilities perform GMP batch testing and batch release for sterile, non-sterile and biological medicinal products. Most of our batch testing clients are global manufacturers from countries without mutual recognition agreements (MRA) who wish to import their products within the European Economic Area (EEA). Here batch testing is mandatory prior to batch release. Our service pack also includes batch release for such manufacturers thus enabling them to entrust us with their products until market release. Our integrated solution for GMP batch testing and batch release includes:

  • Analytical method transfer (AMT)
  • Batch testing according to the approved specifications
  • Batch testing and batch release of clinical and marketing batches
  • Full analysis of all parameters to issue a standalone batch Certificate of Analysis
  • Individual parameter determination to be included in your batch Certificate of Analysis
  • APIs Certificate of Analysis according to relevant pharmacopoeia
  • Requesting Importation Authorization from the Medicines Agency
  • Importation into the EU of drug products (human, veterinary or investigational)
  • Warehousing, sampling, EU depot and shipment (logistic partner)
  • Storing retention and/or reference samples
  • Issuing Qualified Person Declaration for IMPs and marketed products (annex 5.22)
  • Auditing manufacturing supply chain (EU-GMP compliant partner)
  • Managing quality agreement
  • Reviewing shipping documents and transport conditions
  • Managing out-of-specification, change control, deviations and CAPAs
  • Batch manufacturing and packaging records review
  • Batch release in accordance with Marketing Authorization or Clinical Trial regulation (EU) Nº536/2014.

GMP batch testing starts once the AMT has been completed, the relevant documents are approved, and the static data of the product is uploaded into our LIMS (Labware®). Certificates of Analysis (CoA) are issued through LIMS in compliance with USP 21 CFR part 11 and the latest requirements on audit trail and data integrity.

Quality Control laboratory
Laboratory analytist with pipette
Batch Testing and Batch Release

Related Services to Batch Testing and Batch Release

Method Development, Validation and Transfer

Development and validation of analytical methods for excipients, APIs, intermediate products and finished products.

Quality Control of Small Molecules

Analytical tests for APIs, excipients, intermediate products, finished products, packaging materials and process environment samples.

Quality Control of Biologics and Biosimilars

Complex characterization projects for innovative biologics and comparison of biosimilars.

Stability Studies

Full ICH studies and on-going stability programmes at different storage conditions.

Microbiology

Laboratory including cleanroom with airlock technology and HEPA filters for testing of sterile and non-sterile APIs and drug products.

ELEMENTAL, NITROSAMINES  OTHER IMPURITY TESTING

We offer GLP Cell-based neutralizing antibody assays for biologics and GMP Cell-based potency assays for vacines and other biologics.

DO YOU NEED MORE INFORMATION OR A QUOTE?

    You want to stay updated about our innovation projects? Sign up to our newsletter.

    Kymos customer service

    Laboratories

    logo of Kymos

    Barcelona
    Spain

    logo of Prolytic

    Frankfurt
    Germany

    logo of Pharmaprogress

    Ancona
    Italy

    Offices

    Paris
    France

    Milano
    Italy

    Branches

    logo of Kymos for KR branch

    Seoul
    Korea